2015 Wisconsin Dermatological Society Fall Meeting

Milwaukee, WI US
November 14, 2015

This educational activity is designed to enhance the knowledge of the academic and community dermatologists in Wisconsin.  The 2015 WDS Fall Meeting will include five expert lectures on topics including severe atopic dermatitis, management of complex pediatric dermatology, and practical uses for immunofluorescence.  

In addition, virtual patient case presentations will be given highlighting rare and common conditions, as well as treatments.  These patient cases have been selected to demonstrate key points in patient diagnosis and management and will emphasize application of evidence-based medicine and up-to-date references.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 4.5 hours of participation for continuing education for allied health professionals

Target Audience

Dermatologic surgeons
Nurse Practitioners
Physicians Assisants
Dermatology Residents

Learning Objectives

Lisa Beck, MD

  • Understand the constituents of an effective skin barrier and how they are disrupted in atopic dermatitis.
  • Recognize the dynamic interplay between the skin immune dysregulation or skin barrier defects in atopic dermatitis.
  • Be able to discuss therapies that target the immune dysregulation or skin barrier defects in atopic dermatitis.

James Treat, MD

  • Examine how to prevent atopic dermatitis and how to make choices for systemic therapy.
  • Discuss new and emerging "outside jobs".
  • Review under-recognized nutritional deficiencies and contact allergies

Lisa Beck, MD

  • Understand the current guidelines for management of chronic urticaria.
  • Understand how to prescribe omalizumab and the risks and benefits of this rx option.
  • Be able to discuss potential mchanisms by which omalizumab might be working for the treatment of chronic urticaria.

Zelmira Lazarova, MD

  • Review the spectrum of samples processed for DIF in the immunolab for five years.
  • Review the immunopathologic manifestations of unusual immunobullous cases.
  • Recognize usefulness of mucosal biopsy in immunobullous diseases.

Sam Hwang, MD, PhD

  • Understand how mice play key roles in understanding human skin disease.
  • Develop a greater knowledge of the cytokines that are important for human psoriasis.
  • Gain insight as to the role of hemotactic receptors in skin inflammation and how they can be targeted for treatment.
Additional information


Shelly Martin
Phone Number: 
+1 (414) 955-3106
Course summary
Available credit: 
  • 4.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
Course expires: 
Event starts: 
11/14/2015 - 9:00am CST
Event ends: 
11/14/2015 - 2:45pm CST
Medical College of Wisconsin
8701 Watertown Plank Road
Alumni Center
Milwaukee, WI 53226
United States

Shelly Martin, Dawn Siegel, MD; Barbara Wilson, MD; Stephen Humphrey, MD; Angela Jones, PA-C, Lauren Wagner, PA-C, Michelle Bayer, MD; Dianne de Leon, MD; Amy Wentland, MD; JiaDe Yu, MD; Brianne Dickey, MD; Mary Kim, MD; Molly Youssef, MD; Allison Schaus, MD; Michael Lee, MD; Brittany Lister, MD; Krisztian Nemeth, MD, PhD; Lauren Seline, MD; and Laura Tisch, MD

All persons in control of content have NO relevant financial relationships to disclose with the exception of:

Sam Hwang, MD, PhD       Novarits, Abbvie
Yvonne Chiu, MD              Pfizer, Roche
Lisa Beck, MD                  Wyeth Pharmaceuticals, Regeneron, Genentech, Abbvie, Celgene, Janssen, Medimmune, Unilever
James Treat, MD              Up-to-Date

In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  These relationships were reviewed via the MCW conflict of interest resolution process and resolved. 


Available Credit

  • 4.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.50 Hours of Participation
    Hours of Participation credit.


Please login or register to take this course.